Start with the offer
List the products, intended audience and destination the campaign would promote. Read the image, headline, landing page, product details and next step together. A restrained ad does not resolve a destination promoting a different offer. The review needs real business context, not a sanitized description prepared only for an advertiser.
Read the relevant categories
Meta’s Advertising Standards prohibit promotion of illicit or recreational drugs and other unsafe substances. Its Drugs and Pharmaceuticals policy addresses additional restrictions. Product status and advertiser type matter. This article does not certify any particular research peptide, brand or campaign as eligible.
Record the review outcome
Use a short record: what was reviewed, which policy category was relevant, what information is missing and whether the campaign can proceed. Resolve any needed expert product or regulatory assessment before production. The useful output may be a decision to pause, rather than a larger batch of assets. Keep the business owner involved in that decision.
Avoid unsupported promises
A portfolio concept, an old approval or another brand’s active ad is not a guarantee that a new campaign will pass review. Ask a prospective partner how they assess eligibility, document changes and respond to a rejection. A process whose main promise is an account that cannot be restricted deserves careful scrutiny.
Put it into practice
Bring the exact offer and destination to the first conversation. Eligibility review comes before a delivery promise.
Primary references
The workflow above is our practical approach. Review current requirements for the specific offer and market.